Granules India bags USFDA nod for Esomeprazole Magnesium Delayed Release Capsules for GERD symptoms Ruchika Sharma19 Oct 2023 11:31 AM ISTHyderabad: Granules India Limited has announced that the US Food & Drug Administration (US FDA) has approved its Abbreviated New Drug Application...
Granules India bags USFDA nod for Losartan and Hydrochlorothiazide Tablets Ruchika Sharma1 Oct 2023 2:30 PM ISTHyderabad: Granules India Limited announced today that the US Food & Drug Administration (US FDA) has approved its Abbreviated New Drug...
Granules India receives approval from Brazilian Health Regulatory Agency Ruchika Sharma26 Aug 2023 10:00 AM ISTHyderabad: Granules India Limited has announced the receipt of the approval from Brazilian Health Regulatory Agency (ANVISA), for compliance...
Granules India Jeedimetla facility bags accreditation certificate of Foreign Drug Manufacturer from PMDA Ruchika Sharma25 Aug 2023 11:37 AM ISTHyderabad: Granules India Limited has announced that the company has received the Accreditation Certificate of Foreign Drug Manufacturer from...
Granules India reports 62.5 percent fall in Q1 profit Ruchika Sharma10 Aug 2023 1:30 PM ISTRevenue from operations fell 3.3% to 9.85 billion rupees.
USFDA nod to Granules India Metoprolol Succinate ER Tablets Ruchika Sharma9 Aug 2023 11:30 AM ISTTelangana: Granules India has announced that the US Food & Drug Administration (US FDA) has approved the Company’s Abbreviated New Drug...
Granules India completes USFDA audit at Visakhapatnam facility with zero 483 observations Ruchika Sharma3 July 2023 12:30 PM ISTHyderabad: Granules India Limited, a vertically integrated pharmaceutical company, has completed the U.S. Food and Drug Administration’s (US FDA)...
Granules India warns of significant loss of revenue, profitability due to cyber attack Ruchika Sharma29 Jun 2023 3:38 PM ISTThe company said on June 29 that a ransomware group had claimed responsibility for the incident.
Granules India bags USFDA nod for Venlafaxine Hydrochloride ER Capsules Ruchika Sharma19 May 2023 11:30 AM ISTVenlafaxine HCl extended-release capsules are indicated for the treatment of Major Depressive Disorder, Generalized Anxiety Disorder, Social Anxiety...
USFDA nod to Granules India postherpetic neuralgia drug Gabapentin Ruchika Sharma29 March 2023 11:46 AM ISTThe medicine is also indicated as adjunctive therapy in the treatment of partial-onset seizures, with and without secondary generalization, in adults...
Granules India reports 23 percent rise in Q3 profit Ruchika Sharma25 Jan 2023 3:15 PM ISTGranules, which also makes anti-inflammatory drug Ibuprofen, said 45.6 percent of its revenue came from finished dosages, the final...
Granules India net profit up 80 percent at Rs 145 crore in Q2 Ruchika Sharma22 Oct 2022 11:29 AM ISTBengaluru: Pharmaceutical company Granules India Ltd reported an 80% surge in quarterly profit on Thursday, boosted by higher sales of the painkiller...
